These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2882582)

  • 21. [Possibilities and limitations of selective beta 1 adrenergic receptor blockade in clinical practice].
    Ol'binskaia LI; Vartanova OA; Sinopal'nikov AI; Alekseev VG; Logunov OV
    Ter Arkh; 1988; 60(8):31-4. PubMed ID: 3067409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the effects of slow-release metoprolol in chronic coronary insufficiency].
    Armaganijan D; Batlouni M
    Arq Bras Cardiol; 1983 Aug; 41(2):157-9. PubMed ID: 6372751
    [No Abstract]   [Full Text] [Related]  

  • 23. [Physical exertion tolerance in patients with ischemic heart disease associated with cerebral arteriosclerosis].
    Dzizinskiĭ AA; Cherniak BA
    Ter Arkh; 1984; 56(12):28-32. PubMed ID: 6523408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical, ergometric and polygraphic evaluation of the effects of metoprolol and labetalol administration in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Minerva Med; 1982 Apr; 73(14):845-9. PubMed ID: 7070696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benefits from adding nifedipine to the treatment of unstable angina when beta-blockade and isosorbide dinitrate have proved inadequate.
    Hagemeijer F; van Mechelen R; Santoso T
    Herz; 1982 Apr; 7(2):126-31. PubMed ID: 6806163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of strophanthin on cardiovascular function and on tolerance of exercise in patients with angina pectoris treated with beta-adrenergic blocking].
    Volta G; Pavarani A; Barbaresi F; Starcich R
    G Clin Med; 1967 Oct; 48(10):1043-53. PubMed ID: 5605712
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of risk factors on the tolerance to physical exertion in chronic ischemic heart disease].
    Taktuk EE
    Vrach Delo; 1981 Apr; (4):71-4. PubMed ID: 7196644
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of antianginal preparations in ischemic heart disease depending on the duration of the courses of treatment].
    Progonnaia VV
    Vrach Delo; 1988 Jul; (7):29-31. PubMed ID: 3188458
    [No Abstract]   [Full Text] [Related]  

  • 29. [Physical exertion tolerance in middle-aged men in relation to associated risk factors of ischemic heart disease].
    Tokar' AV; Smirnova IP; Fedenko GA; Persidskiĭ IV
    Vrach Delo; 1985 Mar; (3):25-8. PubMed ID: 4013156
    [No Abstract]   [Full Text] [Related]  

  • 30. [Improved exercise tolerance in patients with coronary insufficiency treated with i.v. aminophylline].
    Horacek T; Bischoff KO; Bucher P; Küter L; Hager W
    Med Welt; 1983 Jun; 34(24):694-5. PubMed ID: 6888236
    [No Abstract]   [Full Text] [Related]  

  • 31. [Increased vagal activity after administration of the calcium antagonist diltiazem in patients with coronary heart disease].
    Frey AW; Müller C; Dambacher M; Theisen K
    Z Kardiol; 1995 Feb; 84(2):105-11. PubMed ID: 7717013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Degree of thrombophilia and physical exertion tolerance in patients with stenocardia with different risk factors for ischemic heart disease].
    Gritsiuk AI
    Vrach Delo; 1985 May; (5):56-60. PubMed ID: 4013228
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
    Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA
    Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute influence of beta-adrenergic antagonists on left ventricular diastolic function: contrasting results after administration of celiprolol and metoprolol.
    Modersohn D; Franz N; Heublein B; Panzner B; Walde T; Bruch L
    J Hum Hypertens; 1994 Feb; 8(2):127-32. PubMed ID: 7911530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term metoprolol therapy and neuroleptanesthesia in coronary artery surgery: withdrawal versus maintenance of beta 1-adrenoreceptor blockade.
    Pontén J; Häggendal J; Milocco I; Waldenström A
    Anesth Analg; 1983 Apr; 62(4):380-90. PubMed ID: 6338760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The value of xamoterol in moderate ischemic cardiac insufficiency].
    Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
    Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of passive smoking on the physical tolerance of ischemic heart disease patients].
    Khalfen ESh; Klochkov VA
    Ter Arkh; 1987; 59(5):112-5. PubMed ID: 3616927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.
    Asplund J; Ohman P
    Ann Clin Res; 1981; 13 Suppl 30():30-6. PubMed ID: 7027891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting. The MACB Study Group.
    Eur Heart J; 1995 Dec; 16(12):1825-32. PubMed ID: 8682014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of submaximal physical exertion on the activity of various serum enzymes in patients with ischemic heart disease].
    Markiewicz K; Jazdzewski B; Cholewa M; Cuchro-Cukrowska H
    Kardiol Pol; 1982; 25(5-6):409-16. PubMed ID: 7154486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.